NeoStem (Amex: NBS) 15M units Prices at $0.40 per unit for $6M Public Offering


NYSE Amex: NBS pricing of an underwritten public offering of 15M units at $0.40 per unit and 100% warrant coverage.


Each unit consists of 1 share of common stock and a warrant <100% warrant coverage>to purchase 1 share of common stock with a per share exercise price of $0.51.

  • NBS should receive $6M in gross proceeds, prior to deducting underwriting discounts and commissions and offering expenses payable;
  • NBS has granted the underwriters a 45-day option to purchase up to an additional 2,250,000 units to cover over-allotments. The financing is expected to close on or about 4/3/12.


The Bottom Line: NBS got it done … why be a buyer … pricing … strip the warrant, sell the stock … what institution other than hedge fund flippers … so what … are … the REAL catalysts and milestones? Watch out ahead … even, I would need convincing!!!

NBS is trading down at $0.1144 <-22.42%> at $0.395 @10:13am.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


More on this story


Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

1 day, 7 hours ago

2 min read